In Reply In response to our study,1 Xu and Orlowski suggest that Medicare indirect graduate medical education (GME) payments, effectively 75% of total Medicare GME payments, should be disregarded when considering Medicare’s support for training. While the indirect payment may recognize the higher cost of patient care associated with teaching, it is clearly a payment for GME and should be considered in any policy discussion of this public investment in physician training. Furthermore, a 2010 analysis by the Medicare Payment Advisory Commission (MedPAC)2 found that less than half—only 40% to 45%—of the indirect payments could be empirically justified by higher patient care costs. In 2010, MedPAC recommended redistributing the estimated $3.5 billion in GME overpayments to a new performance-based GME program.2 Our study1 shows that indirect payments have further increased since 2010.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Chen C, Chung Y, Bazemore A. Considerations in Analysis of Medicare Graduate Medical Education Payment Policies—Reply. JAMA Intern Med. 2020;180(3):472–473. doi:10.1001/jamainternmed.2019.6977
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: